ISP Finally Approves Sale in Chile of Generic Version of Slimming Medicine, Ozempic

La Tercera

Lean Right

Factuality

Ownership

With almost a month delay, the ISP finally approved the commercialization in Chile of the generic version of the famous slimming drug, Ozempic (Novo Nordisk). Through a statement, the Institute of Public Health (ISP) approved Picmaggluti, the solution for injection of semaglutide by Dr. Reddy’s Laboratories Chile, which thus becomes the first semaglutide of authorized chemical synthesis in the country. Semaglutide is the active substance of Ozem…

G5noticias

Factuality

Ownership

The ISP authorized an alternative containing the same active substance of Ozempic. The researcher of UNAB Felipe Díaz-Toro highlights its potential to expand access, but warns that clinical results should be evaluated according to each formulation and that the price will be key to its impact on public health. Picmagluti’s approval by [...]

duplos.cl

Factuality

Ownership

The Institute of Public Health authorized the medical registry of Picmagluti, a type 2 diabetes injectable solution developed by laboratory synthesis.